CoChat

New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine

Open access
Song, Pengtao, Li, Biaoru · 2025 · Diagnostics

The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.

Abstract

Following the application of epigenetic and epigenomics research into tumor diseases, cardiovascular disease, diabetes, hereditary diseases, and rare diseases, in vitro diagnostics (IVD) epigenetic and epigenomics are increasingly employed for those patients. Here, we review a clinical sampling of epigenetics and epigenomics from patients. We then present procedures, including the detection procedure of clinical epigenetic approaches from clinical samples, clinical epigenomic methods applied to those samples, the small cell number of epigenetics, and epigenomics. Finally, we present the current IVD of epigenetics and epigenomics used for clinical analysis and diagnosis, along with the development of approaches. To improve clinical study and diagnosis, we also introduce clinical research and clinical applications to develop a more comprehensive strategy to maximize the sensitivity and specificity of the epigenetics and epigenomics analysis and diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/diagnostics15121539

Cites

76 of 77 references verified0 citation errors · 1 not checkable

Statistics

Figures

Figure 1 (A) DNA methylation. Methylation of cytosine is a covalent modification of DNA, in which hydrogen H5 of cytosine is replaced by a methyl group under DNA methyltransferase (DNMT). In mammals, 60–90% of all CpGs are methylated. The pattern of methylation controls protein binding to target sites on DNA, affecting changes in gene expression and in chromatin organization, often silencing genes, which physiologically orchestrates processes like differentiation and pathologically leads to cancer. (B) Histone post-transcriptional modification. Histones H2A, H2B, H3, and H4 are formed as the core histones with some long ‘tails’ located on one end for enzyme modifications, including methylation, acetylation, phosphorylation, and ubiquitination to adjust the regulatory proteins. The most well-understandable amino acids in histone in tumor diseases are H3K4Me3 and H3K36Me3 (activity, red color) and H3K9me2/3 and H3K27me3 (repressor, green color). K = lysine and R = arginine. (C) lncRNA modification.
Figure 1 (A) DNA methylation. Methylation of cytosine is a covalent modification of DNA, in which hydrogen H5 of cytosine is replaced by a methyl group under DNA methyltransferase (DNMT). In mammals, 60–90% of all CpGs are methylated. The pattern of methylation controls protein binding to target sites on DNA, affecting changes in gene expression and in chromatin organization, often silencing genes, which physiologically orchestrates processes like differentiation and pathologically leads to cancer. (B) Histone post-transcriptional modification. Histones H2A, H2B, H3, and H4 are formed as the core histones with some long ‘tails’ located on one end for enzyme modifications, including methylation, acetylation, phosphorylation, and ubiquitination to adjust the regulatory proteins. The most well-understandable amino acids in histone in tumor diseases are H3K4Me3 and H3K36Me3 (activity, red color) and H3K9me2/3 and H3K27me3 (repressor, green color). K = lysine and R = arginine. (C) lncRNA modification.CC BY · PubMed Central
Figure 2 Clinical epigenetic and epigenome analysis. Process from sampling performance, epigenome and epigenome application for DNA hypermethylation, histone modification, and lncRNA for clinical epigenetic and epigenomic analysis and diagnosis. Pink means sampling and abnormal epigenetic changes, which will be discussed in detail in the manual.
Figure 2 Clinical epigenetic and epigenome analysis. Process from sampling performance, epigenome and epigenome application for DNA hypermethylation, histone modification, and lncRNA for clinical epigenetic and epigenomic analysis and diagnosis. Pink means sampling and abnormal epigenetic changes, which will be discussed in detail in the manual.CC BY · PubMed Central
Figure 3 Hypermethylation detection technique. All technologies to detect DNA methylation are classified: Local specific genes which have been successfully employed in both research lab and clinical fields; Genomic regions and global measurement at a genome-wide scale based on sequencing technology and microarray, which have been successfully used in both research and clinical fields; Global measures of DNA methylation, which are often applied for research lab or clinical lab with equipment; and DNMT assay.
Figure 3 Hypermethylation detection technique. All technologies to detect DNA methylation are classified: Local specific genes which have been successfully employed in both research lab and clinical fields; Genomic regions and global measurement at a genome-wide scale based on sequencing technology and microarray, which have been successfully used in both research and clinical fields; Global measures of DNA methylation, which are often applied for research lab or clinical lab with equipment; and DNMT assay.CC BY · PubMed Central
Figure 4 Abnormal histone detection technique. First step is sampling, including cell level and tissue level. Second step is the ChIP process, including crossing-binding, cell lysis, Ab-binding, and DNA purification. Third is the detection step, including ChIP PCR, ChIP-chip, and ChIP-seq.
Figure 4 Abnormal histone detection technique. First step is sampling, including cell level and tissue level. Second step is the ChIP process, including crossing-binding, cell lysis, Ab-binding, and DNA purification. Third is the detection step, including ChIP PCR, ChIP-chip, and ChIP-seq.CC BY · PubMed Central
Figure 5 Abnormal lncRNA detection technique. (A) Specific lncRNA detection by either real-time PCR, (B) lncRNA FISH, (C) genomic detection by microarray, and (D) next-generation RNA sequencing.
Figure 5 Abnormal lncRNA detection technique. (A) Specific lncRNA detection by either real-time PCR, (B) lncRNA FISH, (C) genomic detection by microarray, and (D) next-generation RNA sequencing.CC BY · PubMed Central
Figure 6 Abnormal histone confirmation technique. After abnormal histone modification is discovered, two kinds of confirmation assays for abnormal histone modification have been used in clinical patients: abnormal acetylation histone modification and abnormal histone methylation modification.
Figure 6 Abnormal histone confirmation technique. After abnormal histone modification is discovered, two kinds of confirmation assays for abnormal histone modification have been used in clinical patients: abnormal acetylation histone modification and abnormal histone methylation modification.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Cited by

See all 8

Metadata

Authors
Song, P., & Li, B.
Affiliations
  • Zhejiang Chinese Medical University (CN)
  • School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA
Venue
Diagnostics
Publisher
MDPI AG
Published
2025-06-17
Volume
15
Issue
12
Pages
1539
ISSN
2075-4418 (ISSN-L)
OpenAlex
W4411377817
Cited by
4
References
77
Citations by year
2026: 3 · 2025: 1
FWCI
0.35
Type
journal article
Language
en
Open access
Locations
  • Diagnostics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
in vitro diagnostics, precision medicine, epigenetic biomarkers, epigenomic biomarkers, clinical sample analysis, sensitivity and specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine. https://app.cochat.ai/papers/10.3390/diagnostics15121539
The paper
Song, P., & Li, B. (2025). New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine. Diagnostics. https://doi.org/10.3390/diagnostics15121539

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.